Form S-1/A ReShape Lifesciences
Tweet
Share
E-mailhttp://archive.fast-edgar.com/20250207/ALB4P22C8C22PTZ2222R2ZZZBPHDZ2R23272
Filed on: February 7, 2025
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Mesoblast reaches 300-patient enrollment in back pain Phase 3 trial
- Nuburu launches $38M public offering at 5% premium to fund Tekne deal
- HCC Healthcare signs SPAC deal with RF Acquisition, eyes Nasdaq listing
Create E-mail Alert Related Categories
SEC FilingsRelated Entities
S1Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
